- About 1/4 of the world’s population may not get the Kovid-19 vaccine until 2022
- 3.7 Billion Adults Worldwide Want to Get Kovid-19 Vaccine
- Global warning given in BMJ study report
About a quarter of the world’s population by 2022 Covid-19 (Covid-19) The vaccine will probably not be available. In a study published on Wednesday in ‘The BMJ’, it has been told and warned that distributing the vaccine will be as challenging as developing it. Another study published in the same journal estimated that 3.7 billion adults around the world want to be vaccinated by Kovid-19, creating fair and equitable strategies to ensure supply consistent with demand, especially in low and middle income countries Underlines the importance.
These studies show that the operational challenges of the global COVID-19 vaccination program will be as difficult as the scientific challenges associated with developing the vaccine. Researchers at the Johns Hopkins Bloomberg School of Public Health in the US said, “This study shows how high-income countries have ensured future supply of Covid-19 vaccines, but their reach to the rest of the world remains uncertain.” is.”
Covid-19 Vaccine: Telangana is preparing for vaccination, plans to give vaccine to 8 million people in mid-January
He said that more than half of the doses (51 percent) of vaccines will be available to high-income countries, which are 14 percent of the world’s population, and the remaining doses will be available to low and middle-income countries, while they will get 85 percent of the world’s population. Are more. Researchers said that about a quarter of the world’s population may not get the Kovid-19 vaccine by 2022, and even if all the vaccine manufacturers are able to reach maximum manufacturing capacity, at least one-fifth of the world by 2022 The vaccine will not reach.
Moderna’s Kovid Vaccine Has No Special Concern About Safety: US Regulator
Three months ago, in an Oxfam report, it was claimed that a group of rich countries with 13 percent of the world’s population had purchased a dose of 50 percent of the corona virus vaccine. Based on data collected by analytics company Airfinity, the non-governmental organization currently analyzed deals between five vaccine-producing companies, pharmaceuticals and buyer countries currently undergoing final testing.
Video – Identification of new form of coronavirus in UK
(This news has not been edited by the NDTV team. It is published directly from the Syndicate feed.)